Geres Hana, Krishnan Nupur, Kotchetkov Rouslan
Department of Medicine, Western University, London, ON, Canada.
Department of Medical Sciences, Western University, London, ON, Canada.
Case Rep Oncol. 2023 Aug 2;16(1):568-576. doi: 10.1159/000531592. eCollection 2023 Jan-Dec.
We present a case of lymphocytosis assumed and managed initially as a chronic lymphocytic leukemia. Shortly after initial visit, the patient's condition deteriorated rapidly with hepatosplenomegaly, pleural effusion, ascites, and skin lesions. Flow cytometry (FC) showed the presence of clonal T-cell population, reported as T-cell lymphoma. Due to rapid clinical deterioration, urgent therapy with cyclophosphamide, doxorubicin, vincristine, etoposide, prednisone was initiated, but with minimal response. This prompted further diagnostic testing and demonstrated tumor cells positivity for CD3, CD30, and TCL1 markers. The diagnosis was changed to T-cell prolymphocytic leukemia. The patient responded well to alemtuzumab (anti-CD52 monoclonal antibody) and reached complete remission. FC is an essential modality for assessing and screening circulating lymphocytes when a lymphoproliferative disorder (LPD) is suspected. There are several LPDs that present with different degrees of clonal lymphocytosis. Reactive lymphocytosis should be appropriately investigated. Indolent LPDs can be surveyed by the internist or family physician, while more aggressive LPDs typically require management by hematologists.
我们报告一例最初被假定为慢性淋巴细胞白血病并进行相应处理的淋巴细胞增多症病例。初诊后不久,患者病情迅速恶化,出现肝脾肿大、胸腔积液、腹水及皮肤病变。流式细胞术(FC)显示存在克隆性T细胞群,报告为T细胞淋巴瘤。由于临床病情迅速恶化,遂开始紧急使用环磷酰胺、阿霉素、长春新碱、依托泊苷、泼尼松进行治疗,但反应甚微。这促使进一步进行诊断性检查,并显示肿瘤细胞CD3、CD30和TCL1标记物呈阳性。诊断改为T细胞幼淋巴细胞白血病。患者对阿仑单抗(抗CD52单克隆抗体)反应良好并达到完全缓解。当怀疑存在淋巴细胞增殖性疾病(LPD)时,FC是评估和筛查循环淋巴细胞的重要方法。有几种LPD会出现不同程度的克隆性淋巴细胞增多。应适当调查反应性淋巴细胞增多症。惰性LPD可由内科医生或家庭医生进行检查,而侵袭性更强的LPD通常需要血液科医生进行处理。